Successful adjuvant bi-weekly gemcitabine chemotherapy for pancreatic cancer without impairing patients' quality of life.

MLA

Toyama, Yoichi, et al. “Successful Adjuvant Bi-Weekly Gemcitabine Chemotherapy for Pancreatic Cancer without Impairing Patients’ Quality of Life.” World Journal of Surgical Oncology, vol. 11, no. 1, Jan. 2013, pp. 1–9. EBSCOhost, https://doi.org/10.1186/1477-7819-11-3.

APA

Toyama, Y., Yoshida, S., Saito, R., Kitamura, H., Okui, N., Miyake, R., Ito, R., Son, K., Usuba, T., Nojiri, T., & Yanaga, K. (2013). Successful adjuvant bi-weekly gemcitabine chemotherapy for pancreatic cancer without impairing patients’ quality of life. World Journal of Surgical Oncology, 11(1), 1–9. https://doi.org/10.1186/1477-7819-11-3

Chicago

Toyama, Yoichi, Seiya Yoshida, Ryota Saito, Hiroaki Kitamura, Norimitsu Okui, Ryo Miyake, Ryusuke Ito, et al. 2013. “Successful Adjuvant Bi-Weekly Gemcitabine Chemotherapy for Pancreatic Cancer without Impairing Patients’ Quality of Life.” World Journal of Surgical Oncology 11 (1): 1–9. doi:10.1186/1477-7819-11-3.